AUSTIN, Texas, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the BioCentury 24 Annual Newsmakers in the Biotech Industry conference, being held September 8th at the Millennium Broadway Hotel in New York City.

Presentation Details:
Date: Friday, September 8
Time: 2:00pm Eastern Time
Location: The Millennium Broadway Hotel, Presentation Room 311
Webcast: http://www.wsw.com/webcast/biocentury4/mtem/index.aspx

About Molecular Templates
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates' website at ​www.mtem.com. 


Investor Contact:
Andrew McDonald, Ph.D.
andrew@lifesciadvisors.com
646-597-6987

Molecular Templates

Molecular Templates Inc. published this content on 06 September 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 September 2017 18:32:06 UTC.

Original documenthttp://ir.mtem.com/news-releases/news-release-details/molecular-templates-present-biocentury-24th-annual-newsmakers

Public permalinkhttp://www.publicnow.com/view/F7519E9F9F18260D04D4E439BCD1C895138EFBB3